Cipla Limited
CIPLA
Kedudukan dalam Saham
#1817
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Harga Saham
$14.47
Modal Pasaran
$11.69B
Perubahan (1 hari)
-0.94%
Perubahan (1 tahun)
-23.41%
Negara
IN
Perdagangan Cipla Limited (CIPLA)
Kategori
Healthcare
Sejarah harga saham bagi Cipla Limited (CIPLA)
Harga penutupan tertinggi: $14.60 pada 2026-10-01
Harga penutupan terendah: $0.61 pada 1999-01-01
Harga penutupan terendah: $0.61 pada 1999-01-01
Sejarah harga saham Cipla Limited dari 1999 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | -7.53% |
| 2025 | -3.98% |
| 2024 | 18.60% |
| 2023 | 9.73% |
| 2022 | 11.40% |
| 2021 | 12.45% |
| 2020 | 63.56% |
| 2019 | -11.32% |
| 2018 | -20.85% |
| 2017 | 10.86% |
| 2016 | -13.38% |
| 2015 | -3.99% |
| 2014 | 59.08% |
| 2013 | -16.32% |
| 2012 | 21.62% |
| 2011 | -22.64% |
| 2010 | 8.98% |
| 2009 | 94.47% |
| 2008 | -26.68% |
| 2007 | -6.96% |
| 2006 | 48.26% |
| 2005 | 38.40% |
| 2004 | 24.79% |
| 2003 | 48.49% |
| 2002 | -23.94% |
| 2001 | 11.29% |
| 2000 | -35.33% |
| 1999 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
